Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001209191-23-000951

Options or other derivatives

  • Chief Financial Officer acquired 129,850 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tamboli Ajim Chief Financial Officer 2023-01-03 Grant or award · Stock Option (Right to Buy) +129,850 129,850 D
Loading xslF345X03/doc4.xml…